ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2011
Race and medication adherence and glycemic control: findings from an operational health information exchange.
Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Pooled it
- Glucose control in diabetes: the impact of racial differences on monitoring and outcomes.Endocrine · 2012Pooled it
- Effects of star ratings bonus payments on disparities in medication utilization issues.Exploratory research in clinical and social pharmacy · 2023Article
- Management goal achievements of diabetes care in Iran: study profile and main findings of DiaCare survey.Journal of diabetes and metabolic disorders · 2023Article
- The achievement of comprehensive control targets among type 2 diabetes mellitus patients of different ages.Aging · 2020Article
- Disparities in Initial Oral Antidiabetic Medication Adherence Among Veterans with Incident Diabetes.Journal of managed care & specialty pharmacy · 2018Article
- Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.Clinical and experimental medicine · 2017Article
- Self-Care Disparities Among Adults with Type 2 Diabetes in the USA.Current diabetes reports · 2016Review
- Observational
- Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus.Singapore medical journal · 2015Article
- Association of visit-to-visit variability of hemoglobin A1c and medication adherence.Journal of managed care & specialty pharmacy · 2015Article
- The association between the measurement of adherence to anti-diabetes medicine and the HbA1c.International journal of clinical pharmacy · 2014Review
- Medication treatment complexity and adherence in children with CKD.Clinical journal of the American Society of Nephrology : CJASN · 2014Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Central Indiana Beacon Community leads efforts for improving adherence to oral hypoglycemic agents (OHA) to achieve improvements in glycemic control for patients with type 2 diabetes. In this study, we explored how OHA adherence affected hemoglobin A1C (HbA1c) level in different racial groups. OHA adherence was measured by 6-month proportion of days covered (PDC). Of 3,976 eligible subjects, 12,874 pairs of 6-month PDC and HbA1c levels were formed between 2002 and 2008. The average HbA1c levels were 7.4% for African-Americans and 6.5% for Whites. The average 6-month PDCs were 40% for African-Americans and 50% for Whites. In mixed effect generalized linear regression analyses, OHA adherence was inversely correlated with HbA1c level for both African-Americans (-0.80, p<0.0001) and Whites (-0.53, p<0.0001). The coefficient was -0.26 (p<0.0001) for the interaction of 6-month PDC and African-Americans. Significant risk factors for OHA non-adherence were race, young age, non-commercial insurance, newly-treated status, and polypharmacy.
Indexed as
Identifiers
22195231PMC3243292W197288007What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.